Medigen Vaccine Biologics Corporation (TPEX:6547)

Medigen Vaccine Biologics Revenue

Medigen Vaccine Biologics had revenue of 490.94M TWD in the quarter ending September 30, 2026, with 138.49% growth. This brings the company's total for the last twelve months to 858.93M, up 44.37% year-over-year. In the year 2025, Medigen Vaccine Biologics had annual revenue of 613.17M with 1.24% growth. That makes Medigen Vaccine Biologics the 32,261st largest company in the world by revenue and 1,667th in Taiwan.

• Revenue (ttm): 858.93M
• Revenue Growth: +44.37%
• P/S Ratio: 17.93
• Revenue / Employee: 8.34M
• Employees: 103
• Market Cap: 15.40B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	613.17M	7.53M	1.24%
Dec 31, 2024	605.64M	216.01M	55.44%
Dec 31, 2023	389.62M	24.58M	6.73%
Dec 31, 2022	365.04M	-2.92B	-88.87%
Dec 31, 2021	3.28B	3.27B	28,413.03%

Data Source: S&P Global Market Intelligence Last updated: Nov 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 14, 2026

Data Sources Report a data error